Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers

Information

  • Research Project
  • 9407702
  • ApplicationId
    9407702
  • Core Project Number
    R42GM112750
  • Full Project Number
    2R42GM112750-03A1
  • Serial Number
    112750
  • FOA Number
    PA-16-158
  • Sub Project Id
  • Project Start Date
    9/22/2014 - 10 years ago
  • Project End Date
    8/31/2020 - 4 years ago
  • Program Officer Name
    SHEELEY, DOUGLAS
  • Budget Start Date
    9/8/2017 - 7 years ago
  • Budget End Date
    8/31/2018 - 6 years ago
  • Fiscal Year
    2017
  • Support Year
    03
  • Suffix
    A1
  • Award Notice Date
    9/8/2017 - 7 years ago
Organizations

Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers

Project Summary Glycosylation is one of the most prevalent and important post-translational modifications of proteins, yet it is also one of the most difficult to study. No single method nor analytical platform can give complete information about the glycosylation in a protein sample, and the analytical methods in current use include both ESI and MALDI single and tandem mass spectrometry, at least four types of liquid chromatography, iterative enzyme analysis, glycan-binding experiments with fluorescence read-out, and new methods such as ion mobility spectrometry. There is currently no software platform that can integrate even two of these different data channels. In this project we propose to build a software product called GlycoForm that will be capable of analyzing, visualizing, and integrating glycosylation data over multiple channels. GlycoForm will be able to identify released glycans to the level of detail warranted by the evidence and quantify them using either mass spectrometry or fluorescence signals. The software will include both an interactive user interface for expert inspection, and also customized and automated glycosylation reports for sharing and archiving. The initial release of GlycoForm will handle single and tandem mass spectrometry, chromatographic elution time, and glycan-binding experiments; other data channels will be added later in response to customer demand.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R42
  • Administering IC
    GM
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    315614
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:315614\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PROTEIN METRICS, INC.
  • Organization Department
  • Organization DUNS
    967100921
  • Organization City
    SAN CARLOS
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    940702060
  • Organization District
    UNITED STATES